Related Experiment Video
Updated: Jul 20, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Regulation of cell migration by the C2 domain of the tumor suppressor PTEN
Myrto Raftopoulou1, Sandrine Etienne-Manneville, Annette Self
1Medical Research Council Laboratory for Molecular Cell Biology and Cell Biology Unit, Cancer Research UK Oncogene and Signal Transduction Group, University College London, Gower Street, London WC1E 6BT, UK.
Abstract:
PTEN is a tumor suppressor protein that dephosphorylates phosphatidylinositol 3,4,5 trisphosphate and antagonizes the phosphatidylinositol-3 kinase signaling pathway. We show here that PTEN can also inhibit cell migration through its C2 domain, independent of its lipid phosphatase activity. This activity depends on the protein phosphatase activity of PTEN and on dephosphorylation at a single residue, threonine(383). The ability of PTEN to control cell migration through its C2 domain is likely to be an important feature of its tumor suppressor activity.
Insights
The tumor suppressor protein PTEN inhibits cell migration via its C2 domain, independent of its lipid activity. This function relies on PTEN
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- PTEN (Phosphatase and tensin homolog) is a critical tumor suppressor.
- It antagonizes the PI3K/Akt signaling pathway by dephosphorylating PIP3.
- Its role in regulating cell migration is incompletely understood.
Purpose of the Study:
- To investigate the non-lipid phosphatase functions of PTEN.
- To determine the role of the PTEN C2 domain in regulating cell migration.
- To elucidate the molecular mechanisms underlying PTEN-mediated inhibition of cell migration.
Main Methods:
- Site-directed mutagenesis to alter PTEN protein phosphatase activity.
- Cell migration assays (e.g., transwell assays).
- Western blotting to assess protein phosphorylation status.
Main Results:
- PTEN inhibits cell migration through its C2 domain.
- This inhibition is independent of PTEN's lipid phosphatase activity.
- The C2 domain's function requires PTEN's protein phosphatase activity, specifically dephosphorylation at Threonine 383.
Conclusions:
- PTEN possesses a novel mechanism for inhibiting cell migration via its C2 domain.
- This function is linked to its protein phosphatase activity, not lipid phosphatase activity.
- The C2 domain's role in controlling cell migration is a key aspect of PTEN's tumor suppressor function.
Related Concept Videos
Abnormal Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

